Trial intelligence / Profile preview

Caffeine in Narcoleptic Patients

NCT02832336Phase 2Completed

Sponsor
King Saud University
Start
Oct 2016
Primary completion
May 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of caffeine in narcolepsy, sponsored by King Saud University. Started Oct 2016; status: completed.

02

Drugs

caffeine
03

Conditions

narcolepsy

Beyond the preview

Go deeper on NCT02832336.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02832336.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call